Details

Autor(en) / Beteiligte

• Cheng, C.‐M.
• Wu, Y.‐H.
• Tsai, S.‐J.
• Bai, Y.‐M.
• Hsu, J.‐W.
• Huang, K.‐L.
• Su, T.‐P.
• Li, C.‐T.
• Tsai, C.‐F.
• Yang, A. C.
• Lin, W.‐C.
• Pan, T.‐L.
• Chang, W.‐H.
• Chen, T.‐J.
• Chen, M.‐H.

Titel

Risk of developing Parkinson's disease among patients with asthma: a nationwide longitudinal study

Ist Teil von

• Allergy (Copenhagen), 2015-12, Vol.70 (12), p.1605-1612

Ort / Verlag

Denmark: Blackwell Publishing Ltd

Erscheinungsjahr

2015

Quelle

Wiley-Blackwell Full Collection

Beschreibungen/Notizen

• Background A cross‐sectional retrospective study suggested a link between allergic diseases and Parkinson's disease. However, the temporal association between asthma and Parkinson's disease remains unknown. Methods From the Taiwan National Health Insurance Research Database, 10 455 patients who were diagnosed with asthma between 1998 and 2008 and aged ≥45 years and 41 820 age‐ and sex‐matched controls were selected for our study and observed until the end of 2011. Those who developed Parkinson's disease during the follow‐up period were identified. We also examined the asthma severity, as indicated by the frequency of admission (times per year) for asthma exacerbation, and the risk of subsequent Parkinson's disease. Results Patients with asthma had an increased risk of developing Parkinson's disease (hazard ratio [HR]: 3.10, 95% confidence interval [CI]: 2.20–4.36) after we adjusted for demographic data, health system use, medical comorbidities, and medication use. Sensitivity tests yielded consistent findings after we excluded observations on the first year (HR: 2.90, 95% CI: 2.04–4.13) and first 3 years (HR: 2.46, 95% CI: 1.64–3.69). Patients with asthma who had more frequent admissions (times per year) during the follow‐up period exhibited a greater risk of subsequent Parkinson's disease (>2: HR: 16.42, 95% CI: 5.88–45.91; 1‐2: 12.69, 95% CI: 5.03–31.71; 0‐1: HR: 2.92, 95% CI: 1.91–4.49). Conclusion Patients with asthma had an elevated risk of developing Parkinson's disease later in life, and we observed a dose‐dependent relationship between greater asthma severity and a higher risk of subsequent Parkinson's disease.